Position in CELC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,970,301
+$833,299 QoQ
Shares Held
61,068
-0.8% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 5.495513198401782.ToString("F0")%
Shared 0.ToString("F0")%
None 94.50448680159822.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPTRUST FINANCIAL ADVISORS holds $130,226,430 across 94 Biotechnology names. CELC ranks #5 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,502 | $29,748,185 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,092 | $14,330,361 | |
| 3 | EXEL |
Exelixis, Inc.
|
312,296 | $13,394,375 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
121,088 | $7,825,917 | |
| 5 | CELC |
Celcuity Inc.
This page
|
61,068 | $6,970,301 | |
| 6 | RPRX |
Royalty Pharma plc
|
143,760 | $6,896,167 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
29,900 | $5,969,535 | |
| 8 | INCY |
Incyte Corp
|
53,555 | $5,040,596 |
All Filings in CELC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,970,301 | 61,068 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,137,002 | 61,530 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,336,229 | 67,535 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $7,615,387 | 570,441 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $5,637,366 | 557,603 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,127,376 | 468,096 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,885,348 | 461,794 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,564,775 | 461,830 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $10,092,492 | 467,245 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,938,245 | 544,835 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,053,487 | 552,898 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $6,131,945 | 558,465 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $5,843,986 | 570,145 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,839,063 | 630,911 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $6,357,217 | 633,189 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $45,500 | 5,000 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $46,750 | 5,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $65,950 | 5,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $90,000 | 5,000 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $120,000 | 5,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $71,700 | 5,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $45,800 | 5,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $29,000 | 5,000 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $34,650 | 5,000 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||